US major Johnson & Johnson MedTech announced receiving U.S. 510(k) regulatory clearance for its MONARCH QUEST. This latest advancement in MONARCH navigation technology features AI-powered algorithms and a verified OEC Open interface with the GE HealthCare OEC 3D mobile CBCT Imaging System.
MONARCH QUEST Technology
The MONARCH QUEST platform represents a significant step forward in minimally invasive lung biopsy procedures. It integrates advanced AI algorithms to enhance navigation precision and includes a verified interface with GE HealthCare’s OEC 3D mobile CBCT Imaging System, allowing for real-time imaging support during procedures.
Growth in Robotically Assisted Procedures
While still emerging, the proportion of robotically assisted bronchoscopy in lung biopsy procedures in the US is growing rapidly. The MONARCH platform, as the first robotically assisted bronchoscopy system to market, enables minimally invasive access and visualization of the airway. This technology helps clinical doctors perform precise biopsies on suspected lung nodules, potentially improving diagnostic accuracy and patient outcomes.-Fineline Info & Tech
Leave a Reply